Ulipristal acetate
CAS No. 126784-99-4
Ulipristal acetate ( CDB2914 )
Catalog No. M11121 CAS No. 126784-99-4
Ulipristal acetate(CDB2914) is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 41 | In Stock |
|
10MG | 55 | In Stock |
|
50MG | 113 | In Stock |
|
100MG | 178 | In Stock |
|
200MG | 267 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUlipristal acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionUlipristal acetate(CDB2914) is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma.
-
DescriptionUlipristal acetate(CDB2914) is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma.
-
SynonymsCDB2914
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorPR
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number126784-99-4
-
Formula Weight475.62
-
Molecular FormulaC30H37NO4
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCC([C@@]1(OC(C)=O)CC[C@@]2([H])[C@]3([H])CCC4=CC(CCC4=C3[C@@H](C5=CC=C(N(C)C)C=C5)C[C@]12C)=O)=O
-
Chemical Name(8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pohl O, et al. Int J Clin Pharmacol Ther. 2013 Jan;51(1):26-33.
molnova catalog
related products
-
GDC-0810
GDC-0810 (ARN-810, Brilanestrant) is a non-steroidal, orally bioavailable selective estrogen receptor degrader (SERD) with IC50 of 0.7 nM (ER-α degradation).
-
Pipendoxifene hydroc...
Pipendoxifene hydrochloride is a selective modulator of estrogen receptor.
-
Nafoxidine
Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.